-
In The News /Harald Nusser, Head of Novartis Social Business, explains why educating young people is key to fighting chronic disease in South-East Asia.
-
In The News /Harald Nusser, Head of Novartis Social Business, talks about how the pharmaceutical industry can work with partners to overcome access issues in poor countries.
-
In The News /The Novartis Access one-year report describes first results, early learnings and challenges from our first twelve months on the ground. It also includes external perspectives and country updates,…
-
Featured News /
The Corporate Reputation of Pharma 2019 global report reflects the findings of a survey conducted by PatientView with patient organizations worldwide.
-
Story /Phil Gotwals talks about his vision for the future of business development for research.
-
Featured News /Novartis included in Dow Jones Sustainability World Index, with industry-leading performance in environmental and social reporting and human capital.
-
Story /When a middle-aged firefighter and active Boy Scout leader in the Midwestern United States lost his hearing a few years ago, he also faced the loss of his livelihood.
-
Story /Alice Shaw, Global Head of Translational Clinical Oncology at Novartis, applies lessons from running clinical trials to the work of designing them.
-
Featured News /
Leprosy is an ancient disease that currently infects more than 200 000 people each year. For more than three decades, Novartis and the Novartis Foundation has been working to reduce the incidence of leprosy, and the Novartis Foundation recently helped establish the Global Partnership for Zero Leprosy in an effort to eliminate the disease.
-
Featured News /
The World Health Organization (WHO) passed a resolution on psoriasis that creates an urgent call to action for the international community.
Pagination
- ‹ Previous page
- 1
- …
- 136
- 137
- 138
- 139
- 140
- 141
- 142
- …
- 280
- › Next page